XML 161 R35.htm IDEA: XBRL DOCUMENT v3.25.2
Net Loss Per Share (Tables)
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2025
Jan. 31, 2025
Dec. 31, 2024
Jul. 31, 2024
Titan Pharmaceuticals Inc [Member]        
Schedule of Antidilutive Securities Excluded From Computation of Net Loss Per Common Share

The table below presents common shares underlying stock options and warrants that are excluded from the calculation of the weighted average number of common shares outstanding used for the calculation of diluted net loss per common share. These are excluded from the calculation due to their anti-dilutive effect:

 

   Three Months Ended
   March 31,
(in thousands)  2025  2024
Weighted-average anti-dilutive common shares resulting from options   80    93 
Weighted-average anti-dilutive common shares resulting from convertible note   -    15 
Weighted-average anti-dilutive common shares resulting from convertible preferred   1,019    332 
Weighted-average anti-dilutive common shares resulting from warrants   468    476 
    1,567    916 
  

 

   2024   2023 
   December 31, 
   2024   2023 
Weighted-average anti-dilutive common shares resulting from convertible preferred stock   593    - 
Weighted-average anti-dilutive common shares resulting from convertible notes   7    - 
Weighted-average anti-dilutive common shares resulting from stock options and awards   92    70 
Weighted-average anti-dilutive common shares resulting from warrants   477    427 
Anti-dilutive Securities Excluded from Computation of Earnings Per Share, Amount   1,169    497 
  
TALENTEC SDN. BHD. [Member]        
Schedule of Earning Per Share  

The following table sets forth the basic and diluted earning per share computation and provides a reconciliation of the numerator and denominator for the periods presented:

 

Schedule of Earning Per Share

         
   For the six months ended January 31, 
   2024   2025 
Numerator:        
Net income  $58,172   $294,968 
           
Denominator:          
Weighted average number of ordinary shares   500,000    580,000 
           
Earning per share          
-Basic and diluted  $0.12   $0.51 
  

The following table sets forth the basic and diluted net earnings per share computation and provides a reconciliation of the numerator and denominator for the years presented:

 

         
   As of July 31, 
   2023   2024 
Numerator:          
Net income  $11,686   $153,227 
           
Denominator:          
Weighted average number of ordinary shares   500,000    501,312 
           
Net earnings per share          
-Basic and diluted  $0.02   $0.31